{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:14:24Z","timestamp":1780402464293,"version":"3.54.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.revmed.2026.03.439","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T21:42:36Z","timestamp":1775598156000},"page":"325-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["La myopathie cortisonique\u00a0: physiopathologie, strat\u00e9gie diagnostique et prise en charge"],"prefix":"10.1016","volume":"47","author":[{"given":"Guilhem","family":"Sol\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9gane","family":"Le Quang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Martin-N\u00e9grier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"G\u00e9fard-Gontier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2026.03.439_bib0330","doi-asserted-by":"crossref","first-page":"105278","DOI":"10.1016\/j.envint.2019.105278","article-title":"Determination and occurrence of natural and synthetic glucocorticoids in surface waters","volume":"134","author":"Shen","year":"2020","journal-title":"Environ Int"},{"key":"10.1016\/j.revmed.2026.03.439_bib0335","series-title":"The pituitary body and its disorders. Clinical states produced by disorders of the hypophysis cerebri","author":"Cushing","year":"1912"},{"issue":"4","key":"10.1016\/j.revmed.2026.03.439_bib0340","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jama.1932.02740560007003","article-title":"Further notes on pituitary basophilism","volume":"99","author":"Cushing","year":"1932","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2026.03.439_bib0345","first-page":"143","article-title":"A case of basophil adenoma of the anterior lobe of the pituitary: \u201cCushing's syndrome\u201d","volume":"82","author":"Bishop","year":"1932","journal-title":"Guys Hosp Rep"},{"key":"10.1016\/j.revmed.2026.03.439_bib0350","first-page":"123","article-title":"Cushing's syndrome","volume":"38","author":"Albright","year":"1943","journal-title":"Harvey Lectures"},{"issue":"7","key":"10.1016\/j.revmed.2026.03.439_bib0355","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"20","key":"10.1016\/j.revmed.2026.03.439_bib0360","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM195005182422005","article-title":"The clinical usefulness of ACTH and cortisone (part 1)","volume":"242","author":"Thorn","year":"1950","journal-title":"N Engl J Med"},{"issue":"7075","key":"10.1016\/j.revmed.2026.03.439_bib0365","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(59)91886-0","article-title":"Reversible amyotrophy complicating treatment with fludrocortisone","volume":"1","author":"Maclean","year":"1959","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2026.03.439_bib0370","series-title":"Aids to the examination of the peripheral nervous system. Memorandum No.\u00a045","year":"1986"},{"issue":"779","key":"10.1016\/j.revmed.2026.03.439_bib0375","first-page":"799","article-title":"Maladies musculaires de l\u2019adulte\u00a0: quand \u00e9voquer le diagnostic\u00a0?","volume":"18","author":"Vicino","year":"2022","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.revmed.2026.03.439_bib0380","series-title":"Disorders of voluntary muscle. Cambridge: Cambridge University Press","article-title":"Endocrine and toxic myopathies","author":"Argov","year":"2010"},{"issue":"6","key":"10.1016\/j.revmed.2026.03.439_bib0385","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2125.1978.tb01664.x","article-title":"Prednisone or prednisolone for the treatment of chronic active hepatitis? A comparison of plasma availability","volume":"5","author":"Davis","year":"1978","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.revmed.2026.03.439_bib0390","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.revmed.2026.03.439_bib0395","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0733-8619(03)00053-7","article-title":"Neuromuscular manifestations of endocrine disorders","volume":"20","author":"Alshekhlee","year":"2002","journal-title":"Neurol Clin"},{"issue":"5","key":"10.1016\/j.revmed.2026.03.439_bib0400","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4103\/2230-8210.117215","article-title":"Glucocorticoid-induced myopathy: pathophysiology, diagnosis, and treatment","volume":"17","author":"Gupta","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.revmed.2026.03.439_bib0405","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1152\/japplphysiol.00113.2023","article-title":"The duration of glucocorticoid treatment alters the anabolic response to high-force muscle contractions","volume":"135","author":"Dunlap","year":"2023","journal-title":"J Appl Physiol (1985)"},{"issue":"10","key":"10.1016\/j.revmed.2026.03.439_bib0410","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","article-title":"Glucocorticoid-induced skeletal muscle atrophy","volume":"45","author":"Schakman","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"10.1016\/j.revmed.2026.03.439_bib0415","doi-asserted-by":"crossref","first-page":"e149828","DOI":"10.1172\/JCI149828","article-title":"Intermittent glucocorticoid treatment enhances skeletal muscle performance through sexually dimorphic mechanisms","volume":"132","author":"Salamone","year":"2022","journal-title":"J Clin Invest"},{"issue":"24","key":"10.1016\/j.revmed.2026.03.439_bib0420","doi-asserted-by":"crossref","first-page":"132402","DOI":"10.1172\/jci.insight.132402","article-title":"Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming","volume":"4","author":"Quattrocelli","year":"2019","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.revmed.2026.03.439_bib0425","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/a-2246-2900","article-title":"Glucocorticoid-induced myopathy: typology, pathogenesis, diagnosis, and treatment","volume":"56","author":"Wu","year":"2024","journal-title":"Horm Metab Res"},{"issue":"11","key":"10.1016\/j.revmed.2026.03.439_bib0430","doi-asserted-by":"crossref","first-page":"E983","DOI":"10.1152\/ajpendo.00234.2014","article-title":"REDD1\u00a0deletion prevents dexamethasone-induced skeletal muscle atrophy","volume":"307","author":"Britto","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"335","key":"10.1016\/j.revmed.2026.03.439_bib0435","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2005103","article-title":"REDD1\u00a0enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1\u00a0signaling","volume":"7","author":"Dennis","year":"2014","journal-title":"Sci Signal"},{"issue":"Pt 19","key":"10.1016\/j.revmed.2026.03.439_bib0440","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1113\/jphysiol.2011.212845","article-title":"Muscle sparing in muscle RING finger 1\u00a0null mice: response to synthetic glucocorticoids","volume":"589","author":"Baehr","year":"2011","journal-title":"J Physiol"},{"issue":"2","key":"10.1016\/j.revmed.2026.03.439_bib0445","doi-asserted-by":"crossref","first-page":"E363","DOI":"10.1152\/ajpendo.00487.2002","article-title":"Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression","volume":"285","author":"Ma","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.revmed.2026.03.439_bib0450","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1152\/jappl.1995.78.2.629","article-title":"Corticosteroid treatment and nutritional deprivation cause a different pattern of atrophy in rat diaphragm","volume":"78","author":"Dekhuijzen","year":"1995","journal-title":"J Appl Physiol (1985)"},{"issue":"5","key":"10.1016\/j.revmed.2026.03.439_bib0455","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03347462","article-title":"Steroid myopathy: some unresolved issues","volume":"34","author":"Minetto","year":"2011","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.revmed.2026.03.439_bib0460","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/mus.20915","article-title":"Nitric oxide reverses prednisolone-induced inactivation of muscle satellite cells","volume":"37","author":"Betters","year":"2008","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.revmed.2026.03.439_bib0465","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1164\/ajrccm.159.1.9803021","article-title":"Acute treatment with corticosteroids decreases IGF-1\u00a0and IGF-2\u00a0expression in the rat diaphragm and gastrocnemius","volume":"159","author":"Gayan-Ramirez","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.revmed.2026.03.439_bib0470","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00124743-199906000-00007","article-title":"Drug interactions affecting the efficacy of corticosteroid therapy a brief review with an illustrative case","volume":"5","author":"Feldweg","year":"1999","journal-title":"J Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.revmed.2026.03.439_bib0475","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.taap.2012.03.008","article-title":"Oral and inhaled corticosteroids: differences in P-glycoprotein (ABCB1) mediated efflux","volume":"260","author":"Crowe","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"10.1016\/j.revmed.2026.03.439_bib0480","doi-asserted-by":"crossref","first-page":"17895","DOI":"10.1038\/s41598-023-44792-2","article-title":"Genetic polymorphisms in ABCB1\u00a0are correlated with the increased risk of atorvastatin-induced muscle side effects: a cross-sectional study","volume":"13","author":"Lalatovic","year":"2023","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.revmed.2026.03.439_bib0485","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"PAI-1\u00a0in tissue fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J Cell Physiol"},{"issue":"2","key":"10.1016\/j.revmed.2026.03.439_bib0490","doi-asserted-by":"crossref","first-page":"e240205","DOI":"10.1530\/JOE-24-0205","article-title":"Glucocorticoid excess alters metabolic rate and substrate utilisation via 11beta-HSD1","volume":"263","author":"Heaselgrave","year":"2024","journal-title":"J Endocrinol"},{"key":"10.1016\/j.revmed.2026.03.439_bib0495","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fphys.2015.00012","article-title":"The regulation of muscle mass by endogenous glucocorticoids","volume":"6","author":"Braun","year":"2015","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.revmed.2026.03.439_bib0500","doi-asserted-by":"crossref","first-page":"101628","DOI":"10.1016\/j.disamonth.2023.101628","article-title":"Myopathies of endocrine origin: a review for physicians","volume":"70","author":"Shah","year":"2024","journal-title":"Dis Mon"},{"issue":"5","key":"10.1016\/j.revmed.2026.03.439_bib0505","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/qjmed\/hcy031","article-title":"Acute steroid myopathy: a highly overlooked entity","volume":"111","author":"Haran","year":"2018","journal-title":"QJM"},{"issue":"4","key":"10.1016\/j.revmed.2026.03.439_bib0510","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"issue":"12","key":"10.1016\/j.revmed.2026.03.439_bib0515","doi-asserted-by":"crossref","first-page":"e4490","DOI":"10.1210\/clinem\/dgaa625","article-title":"Persisting muscle dysfunction in Cushing's syndrome despite biochemical remission","volume":"105","author":"Vogel","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.revmed.2026.03.439_bib0520","doi-asserted-by":"crossref","DOI":"10.5014\/ajot.2019.029538","article-title":"Handgrip Strength: a comparison of values obtained from the NHANES and NIH toolbox studies","volume":"73","author":"Bohannon","year":"2019","journal-title":"Am J Occup Ther"},{"issue":"2","key":"10.1016\/j.revmed.2026.03.439_bib0525","doi-asserted-by":"crossref","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","article-title":"A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission","volume":"49","author":"Guralnik","year":"1994","journal-title":"J Gerontol"},{"key":"10.1016\/j.revmed.2026.03.439_bib0530","series-title":"Electromyography and neuromuscular disorders. Clinical-electrophysiologic-ultrasound correlations","article-title":"Myopathy","author":"Preston","year":"2021"},{"key":"10.1016\/j.revmed.2026.03.439_bib0535","doi-asserted-by":"crossref","first-page":"1455867","DOI":"10.3389\/fimmu.2025.1455867","article-title":"The utility of muscle magnetic resonance imaging in idiopathic inflammatory myopathies: a scoping review","volume":"16","author":"Paik","year":"2025","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.revmed.2026.03.439_bib0540","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/mus.27081","article-title":"Muscle ultrasound: present state and future opportunities","volume":"63","author":"Wijntjes","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.revmed.2026.03.439_bib0545","doi-asserted-by":"crossref","first-page":"908727","DOI":"10.3389\/fendo.2022.908727","article-title":"Prevention and treatment of glucocorticoid-induced osteoporosis in adults: consensus recommendations from the Belgian Bone Club","volume":"13","author":"Laurent","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.revmed.2026.03.439_bib0550","first-page":"243","article-title":"Mechanisms for fiber-type specificity of skeletal muscle atrophy","volume":"16","author":"Wang","year":"2013","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"10.1016\/j.revmed.2026.03.439_bib0555","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jbspin.2010.02.025","article-title":"Glucocorticoid-induced myopathy","volume":"78","author":"Pereira","year":"2011","journal-title":"Joint Bone Spine"},{"issue":"7","key":"10.1016\/j.revmed.2026.03.439_bib0560","first-page":"1392","article-title":"Enzyme elevation in patients with juvenile dermatomyositis and steroid myopathy","volume":"33","author":"Naim","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2026.03.439_bib0565","doi-asserted-by":"crossref","first-page":"109434","DOI":"10.1016\/j.steroids.2024.109434","article-title":"Muscle ultrasound to identify prednisone-induced muscle damage in adults with nephrotic syndrome","volume":"207","author":"Wu","year":"2024","journal-title":"Steroids"},{"issue":"8","key":"10.1016\/j.revmed.2026.03.439_bib0570","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.clinph.2019.04.709","article-title":"Quantitative ultrasound of muscle can detect corticosteroid effects","volume":"130","author":"Martucci","year":"2019","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.revmed.2026.03.439_bib0575","series-title":"Muscle biopsy. A practical approach","article-title":"Toxic and drug-induced myopathies","author":"Lane","year":"2013"},{"issue":"Suppl 1","key":"10.1016\/j.revmed.2026.03.439_bib0580","first-page":"27","article-title":"Drug-induced myopathy","volume":"14","author":"Manoj","year":"2019","journal-title":"Indian J Rheumatol"},{"key":"10.1016\/j.revmed.2026.03.439_bib0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/8719284","article-title":"The effects of alternate-day corticosteroids in autoimmune disease patients","volume":"2020","author":"Chaia-Semerena","year":"2020","journal-title":"Autoimmune Diseases"},{"issue":"8","key":"10.1016\/j.revmed.2026.03.439_bib0590","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s10067-018-4073-7","article-title":"Safety and efficacy of alternate-day corticosteroid treatment as adjunctive therapy for rheumatoid arthritis: a comparative study","volume":"37","author":"Suda","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2026.03.439_bib0595","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5152\/ArchRheumatol.2026.10964","article-title":"The impact of resistance exercise program on muscle strength, functional performance, and quality of life in patients with rheumatologic disease receiving high-dose glucocorticoids treatment: a randomized trial","volume":"41","author":"Karacaatli","year":"2026","journal-title":"Arch Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2026.03.439_bib0600","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-61-1-83","article-title":"Evidence that prednisone-induced myopathy is reversed by physical training","volume":"61","author":"Horber","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.revmed.2026.03.439_bib0605","doi-asserted-by":"crossref","first-page":"rkac029","DOI":"10.1093\/rap\/rkac029","article-title":"Nutritional recommendations for patients undergoing prolonged glucocorticoid therapy","volume":"6","author":"Esteves","year":"2022","journal-title":"Rheumatol Adv Pract"},{"issue":"12","key":"10.1016\/j.revmed.2026.03.439_bib0610","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1210\/jc.2011-1600","article-title":"Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001\u20132006","volume":"96","author":"Skversky","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.revmed.2026.03.439_bib0615","first-page":"24","article-title":"Steroid myopathy: pathogenesis and effects of growth hormone and insulin-like growth factor-I administration","volume":"56","author":"Kanda","year":"2001","journal-title":"Horm Res"},{"issue":"6","key":"10.1016\/j.revmed.2026.03.439_bib0620","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/mus.21621","article-title":"Branched-chain amino acids protect against dexamethasone-induced soleus muscle atrophy in rats","volume":"41","author":"Yamamoto","year":"2010","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.revmed.2026.03.439_bib0625","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1152\/japplphysiol.01188.2005","article-title":"Creatine supplementation attenuates corticosteroid-induced muscle wasting and impairment of exercise performance in rats","volume":"102","author":"Menezes","year":"2007","journal-title":"J Appl Physiol (1985)"},{"issue":"7","key":"10.1016\/j.revmed.2026.03.439_bib0630","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1210\/jc.2002-021827","article-title":"Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment","volume":"88","author":"Crawford","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.revmed.2026.03.439_bib0635","doi-asserted-by":"crossref","first-page":"e15657","DOI":"10.14814\/phy2.15657","article-title":"l-carnitine downregulate the muscle wasting effect of glucocorticoids in pemphigus patient: a randomized double-blind placebo-controlled study","volume":"11","author":"Noormohammadi","year":"2023","journal-title":"Physiol Rep"},{"key":"10.1016\/j.revmed.2026.03.439_bib0640","doi-asserted-by":"crossref","first-page":"646171","DOI":"10.1155\/2015\/646171","article-title":"Potential therapeutic role of L-carnitine in skeletal muscle oxidative stress and atrophy conditions","volume":"2015","author":"Montesano","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.revmed.2026.03.439_bib0645","doi-asserted-by":"crossref","first-page":"1016687","DOI":"10.3389\/fendo.2022.1016687","article-title":"Concurrence of osteonecrosis and steroid myopathy secondary to oral steroid therapy in a patient with ABCB1\u00a0gene polymorphisms: a case report","volume":"13","author":"Hu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"19","key":"10.1016\/j.revmed.2026.03.439_bib0650","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.3390\/ijms21197066","article-title":"PAI-1, the plasminogen system, and skeletal muscle","volume":"21","author":"Rahman","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866326005230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866326005230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:57:27Z","timestamp":1780401447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866326005230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0248866326005230"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2026.03.439","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La myopathie cortisonique\u00a0: physiopathologie, strat\u00e9gie diagnostique et prise en charge","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2026.03.439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}